2 years ago

Eventum Orthopaedics Secures £2.5 Million in Series A for Knee Replacement Device

  • Eventum Orthopaedics, a UK-based medtech company developing a device for knee replacement surgery, has raised £2.5 million in Series A funding

  • The round was led by NPIF – Mercia Equity Finance, with participation from Mercia, Mercia's EIS funds, and private investors

  • The company plans to use the funds for production, sales and technical team expansion, and FDA approval in the US

  • Eventum's device, Quadsense, measures the forces of a patient's quadriceps muscles during surgery, allowing surgeons to position the kneecap to restore normal knee function.

      • ProblemHealthcare

      "Enhancing the effectiveness of knee replacement surgeries by accurately balancing the quadriceps muscles to restore normal knee function."

      Solution

      "Eventum Orthopaedics has developed Quadsense, a device that measures the forces of a patient’s quadriceps muscles across the range of leg motions before and during surgery, enabling surgeons to position the kneecap for optimal muscle balance and functional recovery."

      Covered on